RT Journal Article
SR Electronic
T1 Tigilanol tiglate is an oncolytic small molecule that induces immunogenic cell death and enhances the response of both target and non-injected tumors to immune checkpoint blockade
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006602
DO 10.1136/jitc-2022-006602
VO 12
IS 4
A1 Cullen, Jason K
A1 Yap, Pei-Yi
A1 Ferguson, Blake
A1 Bruce, Zara C
A1 Koyama, Motoko
A1 Handoko, Herlina
A1 Hendrawan, Kevin
A1 Simmons, Jacinta L
A1 Brooks, Kelly M
A1 Johns, Jenny
A1 Wilson, Emily S
A1 de Souza, Marjorie M A
A1 Broit, Natasa
A1 Stewart, Praphaporn
A1 Shelley, Daniel
A1 McMahon, Tracey
A1 Ogbourne, Steven M
A1 Nguyen, Tam Hong
A1 Lim, Yi Chieh
A1 Pagani, Alberto
A1 Appendino, Giovanni
A1 Gordon, Victoria A
A1 Reddell, Paul W
A1 Boyle, Glen M
A1 Parsons, Peter G
YR 2024
UL http://jitc.bmj.com/content/12/4/e006602.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.